Intervention Effect of Yizhi Baduanjin on Patients With Mild Cognitive Impairment
Research, Development and Promotion of the Service Package of Yizhi Baduanjin for Mild Cognitive Impairment
1 other identifier
interventional
100
0 countries
N/A
Brief Summary
With mild cognitive impairment (MCI) as the research object, the intervention effect of Yizhi Baduanjin on mild cognitive impairment was evaluated by using the Montreal Cognitive Assessment (MoCA) scale, human-computer interactive electronic cognitive function score, multi-measure EEG data and other evaluation indicators, with the intervention measures of Yizhi Baduanjin created by the Tai Chi Health Center in the early stage. This project is based on the preliminary study, followed the principles and methods of clinical epidemiology and evidence-based medicine, and designed a prospective, randomized, single-blind, parallel controlled trial to make up for the deficiency of existing drugs in the intervention of mild cognitive impairment, and to provide evidence for the clinical and community promotion and application of effective and safe traditional Chinese medicine non-pharmaceuticals in the prevention and treatment of mild cognitive impairment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2023
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 17, 2023
CompletedStudy Start
First participant enrolled
June 1, 2023
CompletedFirst Posted
Study publicly available on registry
June 12, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2023
CompletedJune 12, 2023
February 1, 2023
4 months
April 17, 2023
June 1, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
MoCA
The MoCA (Montreal Cognitive Assessment) is a tool used to assess cognitive function, primarily for the early detection of mild cognitive impairment and dementia. The MoCA scale consists of 30 questions, including evaluations of memory, attention, language, abstraction, orientation, spatial ability, and executive function. The scale includes more specific testing items, such as clock-drawing, reaction time, and number string recall. Each question has a standard answer or scoring criteria, and scores are totaled to a maximum of 30 points.The cutoffs for MCI are \<26.
Change from Baseline MOCA at 4 weeks
MoCA
The MoCA (Montreal Cognitive Assessment) is a tool used to assess cognitive function, primarily for the early detection of mild cognitive impairment and dementia. The MoCA scale consists of 30 questions, including evaluations of memory, attention, language, abstraction, orientation, spatial ability, and executive function. The scale includes more specific testing items, such as clock-drawing, reaction time, and number string recall. Each question has a standard answer or scoring criteria, and scores are totaled to a maximum of 30 points.The cutoffs for MCI are \<26.
Change from 4 weeks MOCA at 12 weeks
MoCA
The MoCA (Montreal Cognitive Assessment) is a tool used to assess cognitive function, primarily for the early detection of mild cognitive impairment and dementia. The MoCA scale consists of 30 questions, including evaluations of memory, attention, language, abstraction, orientation, spatial ability, and executive function. The scale includes more specific testing items, such as clock-drawing, reaction time, and number string recall. Each question has a standard answer or scoring criteria, and scores are totaled to a maximum of 30 points.The cutoffs for MCI are \<26.
Change from 12 weeks MOCA at 24 weeks
Secondary Outcomes (6)
Cognitive Function Score
Change from Baseline cognitive function score at 4 weeks
Cognitive Function Score
Change from 4 weeks cognitive function score at 12 weeks
Cognitive Function Score
Change from 12 weeks cognitive function score at 24 weeks
EEG data
Change from Baseline EEG data at 4 weeks
EEG data
Change from 4 weeks EEG data at 12 weeks
- +1 more secondary outcomes
Study Arms (2)
Treatment group
EXPERIMENTALAfter proficiently mastering the complete set of Yizhi Baduanjin, the practice group is required to practice sitting posture of YizhiBaduanjin twice a day and standing posture of YizhiBaduanjin once every two days.
control group
NO INTERVENTIONThe control group is a waiting control group, and after 24 weeks, they will continue to learn the Yizhi Baduanjin.
Interventions
Yizhi Baduanjin is a newly compiled routine developed on the foundation of the traditional Baduanjin, aiming at the mental and cerebral health of middle-aged and elderly population, which combining the preliminary research result and principles of the traditional routine. It could be practiced in long term to prevent MCI and AD, or simply as a general health exercise for elders.
Eligibility Criteria
You may qualify if:
- Subjective symptoms include memory loss
- MoCA score is less than 26 points
- No disability, no communication barrier, and can complete the cognitive function test of human-computer interaction
- Agree to participate in the project and sign the informed consent form
You may not qualify if:
- Alzheimer's patients
- Cognitive impairment caused by depression, cerebrovascular accident and other specific reasons
- Those who are unwilling or unable to take part in the Yizhi Baduanjin exercise
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 17, 2023
First Posted
June 12, 2023
Study Start
June 1, 2023
Primary Completion
October 1, 2023
Study Completion
December 1, 2023
Last Updated
June 12, 2023
Record last verified: 2023-02
Data Sharing
- IPD Sharing
- Will not share